Citations 1
Rapid Response, Unexpected Risk: A ROS1-Positive Non-Small Cell Lung Cancer (NSCLC) Case with Lazarus Syndrome and Fatal Thrombosis
Patrathiranond, Piraya, Thitvirachawat, Sasipim, Eiamprapaporn, P., Thitvirachawat, Sasipim, Eiamprapaporn, Panuch
Asian Medical Journal and Alternative Medicine | April 10, 2026 | Volume: 26 | Issue: 1 | Pages: 56-59
A 57-year-old woman with a ROS1-rearranged NSCLC patient demonstrated a Lazarus response to crizotinib but later developed recurrent pulmonary embolism (PE) with right ventricular (RV) failure. This incident highlights the potential crizotinib-related thrombotic risk and the need for appropriate monitoring of vascular complications, particularly in limited-option settings such as Thailand.